nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.094	0.134	CbGbCtD
Pioglitazone—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0601	0.0859	CbGbCtD
Pioglitazone—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0601	0.0859	CbGbCtD
Pioglitazone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0543	0.0776	CbGbCtD
Pioglitazone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.05	0.0714	CbGbCtD
Pioglitazone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.05	0.0714	CbGbCtD
Pioglitazone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0457	0.0653	CbGbCtD
Pioglitazone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0457	0.0653	CbGbCtD
Pioglitazone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0407	0.0582	CbGbCtD
Pioglitazone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0383	0.0548	CbGbCtD
Pioglitazone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0379	0.0541	CbGbCtD
Pioglitazone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0259	0.037	CbGbCtD
Pioglitazone—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0252	0.0361	CbGbCtD
Pioglitazone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0247	0.0353	CbGbCtD
Pioglitazone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.022	0.0315	CbGbCtD
Pioglitazone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0129	0.0185	CbGbCtD
Pioglitazone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0122	0.0174	CbGbCtD
Pioglitazone—Rosiglitazone—CYP1A2—chronic obstructive pulmonary disease	0.00249	0.634	CrCbGaD
Pioglitazone—Rosiglitazone—ALB—chronic obstructive pulmonary disease	0.00144	0.366	CrCbGaD
Pioglitazone—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.000606	0.00285	CcSEcCtD
Pioglitazone—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000606	0.00285	CcSEcCtD
Pioglitazone—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000606	0.00285	CcSEcCtD
Pioglitazone—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.00281	CcSEcCtD
Pioglitazone—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000595	0.0028	CcSEcCtD
Pioglitazone—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000594	0.00279	CcSEcCtD
Pioglitazone—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000588	0.00276	CcSEcCtD
Pioglitazone—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000588	0.00276	CcSEcCtD
Pioglitazone—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000585	0.00275	CcSEcCtD
Pioglitazone—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000585	0.00275	CcSEcCtD
Pioglitazone—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000584	0.00275	CcSEcCtD
Pioglitazone—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000584	0.00274	CcSEcCtD
Pioglitazone—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000583	0.00274	CcSEcCtD
Pioglitazone—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000583	0.00274	CcSEcCtD
Pioglitazone—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000582	0.00274	CcSEcCtD
Pioglitazone—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000582	0.00274	CcSEcCtD
Pioglitazone—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000581	0.00273	CcSEcCtD
Pioglitazone—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000581	0.00273	CcSEcCtD
Pioglitazone—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00058	0.00273	CcSEcCtD
Pioglitazone—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000577	0.00271	CcSEcCtD
Pioglitazone—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000576	0.00271	CcSEcCtD
Pioglitazone—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.000573	0.00269	CcSEcCtD
Pioglitazone—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000573	0.00269	CcSEcCtD
Pioglitazone—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000571	0.00268	CcSEcCtD
Pioglitazone—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000571	0.00268	CcSEcCtD
Pioglitazone—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00057	0.00268	CcSEcCtD
Pioglitazone—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000569	0.00267	CcSEcCtD
Pioglitazone—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.000569	0.00267	CcSEcCtD
Pioglitazone—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000567	0.00267	CcSEcCtD
Pioglitazone—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000556	0.00261	CcSEcCtD
Pioglitazone—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00261	CcSEcCtD
Pioglitazone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000553	0.0026	CcSEcCtD
Pioglitazone—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000552	0.0026	CcSEcCtD
Pioglitazone—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000552	0.00259	CcSEcCtD
Pioglitazone—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00055	0.00258	CcSEcCtD
Pioglitazone—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00055	0.00258	CcSEcCtD
Pioglitazone—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00258	CcSEcCtD
Pioglitazone—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000549	0.00258	CcSEcCtD
Pioglitazone—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000548	0.00258	CcSEcCtD
Pioglitazone—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00258	CcSEcCtD
Pioglitazone—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000544	0.00256	CcSEcCtD
Pioglitazone—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000544	0.00256	CcSEcCtD
Pioglitazone—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000544	0.00256	CcSEcCtD
Pioglitazone—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000542	0.00255	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00054	0.00254	CcSEcCtD
Pioglitazone—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000538	0.00253	CcSEcCtD
Pioglitazone—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000535	0.00251	CcSEcCtD
Pioglitazone—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000535	0.00251	CcSEcCtD
Pioglitazone—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000534	0.00251	CcSEcCtD
Pioglitazone—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000534	0.00251	CcSEcCtD
Pioglitazone—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.000533	0.0025	CcSEcCtD
Pioglitazone—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000524	0.00246	CcSEcCtD
Pioglitazone—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000523	0.00246	CcSEcCtD
Pioglitazone—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000521	0.00245	CcSEcCtD
Pioglitazone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000519	0.00244	CcSEcCtD
Pioglitazone—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.00244	CcSEcCtD
Pioglitazone—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000518	0.00243	CcSEcCtD
Pioglitazone—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000516	0.00242	CcSEcCtD
Pioglitazone—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000516	0.00242	CcSEcCtD
Pioglitazone—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000511	0.0024	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000511	0.0024	CcSEcCtD
Pioglitazone—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000506	0.00238	CcSEcCtD
Pioglitazone—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000505	0.00237	CcSEcCtD
Pioglitazone—Injury—Prednisolone—chronic obstructive pulmonary disease	0.000504	0.00237	CcSEcCtD
Pioglitazone—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000504	0.00237	CcSEcCtD
Pioglitazone—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.0005	0.00235	CcSEcCtD
Pioglitazone—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000499	0.00234	CcSEcCtD
Pioglitazone—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000499	0.00234	CcSEcCtD
Pioglitazone—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000496	0.00233	CcSEcCtD
Pioglitazone—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000496	0.00233	CcSEcCtD
Pioglitazone—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000494	0.00232	CcSEcCtD
Pioglitazone—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000489	0.0023	CcSEcCtD
Pioglitazone—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.00229	CcSEcCtD
Pioglitazone—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000486	0.00228	CcSEcCtD
Pioglitazone—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00048	0.00225	CcSEcCtD
Pioglitazone—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000478	0.00225	CcSEcCtD
Pioglitazone—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000478	0.00225	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00223	CcSEcCtD
Pioglitazone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000472	0.00222	CcSEcCtD
Pioglitazone—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000471	0.00221	CcSEcCtD
Pioglitazone—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000471	0.00221	CcSEcCtD
Pioglitazone—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000471	0.00221	CcSEcCtD
Pioglitazone—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000468	0.0022	CcSEcCtD
Pioglitazone—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000465	0.00218	CcSEcCtD
Pioglitazone—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000465	0.00218	CcSEcCtD
Pioglitazone—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000461	0.00217	CcSEcCtD
Pioglitazone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.00212	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00045	0.00212	CcSEcCtD
Pioglitazone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000445	0.00209	CcSEcCtD
Pioglitazone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000445	0.00209	CcSEcCtD
Pioglitazone—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000445	0.00209	CcSEcCtD
Pioglitazone—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000441	0.00207	CcSEcCtD
Pioglitazone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000439	0.00206	CcSEcCtD
Pioglitazone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000439	0.00206	CcSEcCtD
Pioglitazone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000439	0.00206	CcSEcCtD
Pioglitazone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000439	0.00206	CcSEcCtD
Pioglitazone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000439	0.00206	CcSEcCtD
Pioglitazone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000439	0.00206	CcSEcCtD
Pioglitazone—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000439	0.00206	CcSEcCtD
Pioglitazone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000439	0.00206	CcSEcCtD
Pioglitazone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000437	0.00206	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000436	0.00205	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000436	0.00205	CcSEcCtD
Pioglitazone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000434	0.00204	CcSEcCtD
Pioglitazone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000434	0.00204	CcSEcCtD
Pioglitazone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00202	CcSEcCtD
Pioglitazone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00202	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00201	CcSEcCtD
Pioglitazone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.00198	CcSEcCtD
Pioglitazone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000421	0.00198	CcSEcCtD
Pioglitazone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000421	0.00198	CcSEcCtD
Pioglitazone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.00198	CcSEcCtD
Pioglitazone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00042	0.00198	CcSEcCtD
Pioglitazone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.00196	CcSEcCtD
Pioglitazone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000418	0.00196	CcSEcCtD
Pioglitazone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00195	CcSEcCtD
Pioglitazone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00195	CcSEcCtD
Pioglitazone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00195	CcSEcCtD
Pioglitazone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000414	0.00195	CcSEcCtD
Pioglitazone—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00194	CcSEcCtD
Pioglitazone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.00194	CcSEcCtD
Pioglitazone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000413	0.00194	CcSEcCtD
Pioglitazone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000412	0.00194	CcSEcCtD
Pioglitazone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000412	0.00194	CcSEcCtD
Pioglitazone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00041	0.00192	CcSEcCtD
Pioglitazone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000409	0.00192	CcSEcCtD
Pioglitazone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000409	0.00192	CcSEcCtD
Pioglitazone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000409	0.00192	CcSEcCtD
Pioglitazone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000407	0.00191	CcSEcCtD
Pioglitazone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000404	0.0019	CcSEcCtD
Pioglitazone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.0004	0.00188	CcSEcCtD
Pioglitazone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00187	CcSEcCtD
Pioglitazone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00187	CcSEcCtD
Pioglitazone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00185	CcSEcCtD
Pioglitazone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.00183	CcSEcCtD
Pioglitazone—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000387	0.00182	CcSEcCtD
Pioglitazone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00181	CcSEcCtD
Pioglitazone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000384	0.00181	CcSEcCtD
Pioglitazone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.0018	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000383	0.0018	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.0018	CcSEcCtD
Pioglitazone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00179	CcSEcCtD
Pioglitazone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00179	CcSEcCtD
Pioglitazone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000378	0.00178	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000376	0.00176	CcSEcCtD
Pioglitazone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00176	CcSEcCtD
Pioglitazone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00176	CcSEcCtD
Pioglitazone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00175	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000372	0.00175	CcSEcCtD
Pioglitazone—Injury—Prednisone—chronic obstructive pulmonary disease	0.000367	0.00172	CcSEcCtD
Pioglitazone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000366	0.00172	CcSEcCtD
Pioglitazone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.00171	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00171	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00171	CcSEcCtD
Pioglitazone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000363	0.0017	CcSEcCtD
Pioglitazone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.0017	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.0017	CcSEcCtD
Pioglitazone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00169	CcSEcCtD
Pioglitazone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000359	0.00169	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00167	CcSEcCtD
Pioglitazone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000355	0.00167	CcSEcCtD
Pioglitazone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00166	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000352	0.00166	CcSEcCtD
Pioglitazone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00035	0.00165	CcSEcCtD
Pioglitazone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00163	CcSEcCtD
Pioglitazone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00163	CcSEcCtD
Pioglitazone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000346	0.00163	CcSEcCtD
Pioglitazone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000345	0.00162	CcSEcCtD
Pioglitazone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000345	0.00162	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00161	CcSEcCtD
Pioglitazone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00161	CcSEcCtD
Pioglitazone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.00157	CcSEcCtD
Pioglitazone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000334	0.00157	CcSEcCtD
Pioglitazone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000327	0.00154	CcSEcCtD
Pioglitazone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00154	CcSEcCtD
Pioglitazone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000327	0.00153	CcSEcCtD
Pioglitazone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00148	CcSEcCtD
Pioglitazone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00031	0.00146	CcSEcCtD
Pioglitazone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.00146	CcSEcCtD
Pioglitazone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000309	0.00145	CcSEcCtD
Pioglitazone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00143	CcSEcCtD
Pioglitazone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000302	0.00142	CcSEcCtD
Pioglitazone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.00142	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000297	0.0014	CcSEcCtD
Pioglitazone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000296	0.00139	CcSEcCtD
Pioglitazone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00138	CcSEcCtD
Pioglitazone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000288	0.00135	CcSEcCtD
Pioglitazone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.00135	CcSEcCtD
Pioglitazone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00134	CcSEcCtD
Pioglitazone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00133	CcSEcCtD
Pioglitazone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00131	CcSEcCtD
Pioglitazone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00131	CcSEcCtD
Pioglitazone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000273	0.00128	CcSEcCtD
Pioglitazone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00128	CcSEcCtD
Pioglitazone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000268	0.00126	CcSEcCtD
Pioglitazone—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00125	CcSEcCtD
Pioglitazone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00124	CcSEcCtD
Pioglitazone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00124	CcSEcCtD
Pioglitazone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00124	CcSEcCtD
Pioglitazone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00123	CcSEcCtD
Pioglitazone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00123	CcSEcCtD
Pioglitazone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.00122	CcSEcCtD
Pioglitazone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00121	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000256	0.0012	CcSEcCtD
Pioglitazone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.0012	CcSEcCtD
Pioglitazone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000255	0.0012	CcSEcCtD
Pioglitazone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.00118	CcSEcCtD
Pioglitazone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.00118	CcSEcCtD
Pioglitazone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00117	CcSEcCtD
Pioglitazone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000241	0.00113	CcSEcCtD
Pioglitazone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.0011	CcSEcCtD
Pioglitazone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00108	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.00107	CcSEcCtD
Pioglitazone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.00107	CcSEcCtD
Pioglitazone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.00104	CcSEcCtD
Pioglitazone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00102	CcSEcCtD
Pioglitazone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000989	CcSEcCtD
Pioglitazone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000969	CcSEcCtD
Pioglitazone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000953	CcSEcCtD
Pioglitazone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000885	CcSEcCtD
Pioglitazone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.000882	CcSEcCtD
Pioglitazone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000881	CcSEcCtD
Pioglitazone—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000871	CcSEcCtD
Pioglitazone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000183	0.00086	CcSEcCtD
Pioglitazone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000857	CcSEcCtD
Pioglitazone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000851	CcSEcCtD
Pioglitazone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000823	CcSEcCtD
Pioglitazone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000812	CcSEcCtD
Pioglitazone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000812	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000806	CcSEcCtD
Pioglitazone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000802	CcSEcCtD
Pioglitazone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000789	CcSEcCtD
Pioglitazone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000778	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000778	CcSEcCtD
Pioglitazone—Infection—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000773	CcSEcCtD
Pioglitazone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000763	CcSEcCtD
Pioglitazone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000756	CcSEcCtD
Pioglitazone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000752	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000709	CcSEcCtD
Pioglitazone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000708	CcSEcCtD
Pioglitazone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000704	CcSEcCtD
Pioglitazone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000671	CcSEcCtD
Pioglitazone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.000671	CcSEcCtD
Pioglitazone—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000141	0.00169	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00014	0.00167	CbGpPWpGaD
Pioglitazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.00163	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000641	CcSEcCtD
Pioglitazone—PPARG—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000135	0.00161	CbGpPWpGaD
Pioglitazone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00161	CbGpPWpGaD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—chronic obstructive pulmonary disease	0.000134	0.00161	CbGpPWpGaD
Pioglitazone—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.0016	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000132	0.00158	CbGpPWpGaD
Pioglitazone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000618	CcSEcCtD
Pioglitazone—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00013	0.00156	CbGpPWpGaD
Pioglitazone—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00013	0.00155	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000126	0.0015	CbGpPWpGaD
Pioglitazone—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00147	CbGpPWpGaD
Pioglitazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00147	CbGpPWpGaD
Pioglitazone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00147	CbGpPWpGaD
Pioglitazone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000573	CcSEcCtD
Pioglitazone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00146	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.00012	0.00143	CbGpPWpGaD
Pioglitazone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000558	CcSEcCtD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000118	0.00141	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000118	0.00141	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000117	0.00139	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000116	0.00139	CbGpPWpGaD
Pioglitazone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000532	CcSEcCtD
Pioglitazone—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000111	0.00133	CbGpPWpGaD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00132	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00011	0.00131	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00131	CbGpPWpGaD
Pioglitazone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000515	CcSEcCtD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.0013	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000108	0.00129	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.00129	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000107	0.00128	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000107	0.00128	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GC—chronic obstructive pulmonary disease	0.000107	0.00128	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000106	0.00127	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000106	0.00126	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000106	0.00126	CbGpPWpGaD
Pioglitazone—Headache—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000488	CcSEcCtD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000101	0.00121	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000101	0.0012	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.93e-05	0.00119	CbGpPWpGaD
Pioglitazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.92e-05	0.00119	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	9.91e-05	0.00119	CbGpPWpGaD
Pioglitazone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.79e-05	0.00117	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.78e-05	0.00117	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.64e-05	0.00115	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	9.46e-05	0.00113	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.37e-05	0.00112	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.29e-05	0.00111	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.26e-05	0.00111	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.13e-05	0.00109	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GC—chronic obstructive pulmonary disease	9.12e-05	0.00109	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.01e-05	0.00108	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.99e-05	0.00108	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.91e-05	0.00107	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.87e-05	0.00106	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—TNF—chronic obstructive pulmonary disease	8.83e-05	0.00106	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.79e-05	0.00105	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.52e-05	0.00102	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.48e-05	0.00101	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	8.45e-05	0.00101	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.39e-05	0.001	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.28e-05	0.00099	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.27e-05	0.000989	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.15e-05	0.000975	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.04e-05	0.000962	CbGpPWpGaD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.04e-05	0.000961	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.96e-05	0.000952	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.94e-05	0.00095	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.91e-05	0.000946	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.85e-05	0.000938	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.54e-05	0.000901	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.5e-05	0.000897	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.49e-05	0.000896	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.43e-05	0.000889	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.4e-05	0.000884	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.39e-05	0.000884	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.38e-05	0.000882	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.33e-05	0.000877	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.32e-05	0.000875	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	7.18e-05	0.000858	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—IL6—chronic obstructive pulmonary disease	7.13e-05	0.000852	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.1e-05	0.000849	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.07e-05	0.000846	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.07e-05	0.000845	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.01e-05	0.000838	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.99e-05	0.000836	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.89e-05	0.000824	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.83e-05	0.000817	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	6.82e-05	0.000816	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.8e-05	0.000813	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.76e-05	0.000809	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.75e-05	0.000808	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.74e-05	0.000806	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.67e-05	0.000798	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.57e-05	0.000785	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—LEP—chronic obstructive pulmonary disease	6.56e-05	0.000785	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.53e-05	0.000781	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.51e-05	0.000779	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.48e-05	0.000774	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.44e-05	0.00077	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	6.4e-05	0.000766	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.39e-05	0.000764	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	6.39e-05	0.000764	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.94e-05	0.00071	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.88e-05	0.000703	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.84e-05	0.000698	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.8e-05	0.000693	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—CTGF—chronic obstructive pulmonary disease	5.78e-05	0.000691	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	5.77e-05	0.00069	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.72e-05	0.000684	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	5.71e-05	0.000683	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	5.5e-05	0.000657	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	5.47e-05	0.000654	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.38e-05	0.000644	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.38e-05	0.000643	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.32e-05	0.000636	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	5.27e-05	0.00063	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.26e-05	0.000628	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.21e-05	0.000623	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.12e-05	0.000612	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	5.03e-05	0.000601	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.98e-05	0.000596	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GCLC—chronic obstructive pulmonary disease	4.92e-05	0.000589	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.9e-05	0.000586	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.85e-05	0.00058	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.84e-05	0.000578	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.73e-05	0.000566	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.59e-05	0.000549	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.56e-05	0.000546	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.51e-05	0.000539	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CTGF—chronic obstructive pulmonary disease	4.49e-05	0.000537	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.44e-05	0.000531	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.27e-05	0.000511	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.24e-05	0.000507	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.21e-05	0.000504	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.21e-05	0.000503	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.14e-05	0.000495	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	4.13e-05	0.000493	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.07e-05	0.000487	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.05e-05	0.000484	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.99e-05	0.000477	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.94e-05	0.000472	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.92e-05	0.000469	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.88e-05	0.000464	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.84e-05	0.000459	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.79e-05	0.000453	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.75e-05	0.000449	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.72e-05	0.000445	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.71e-05	0.000444	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.68e-05	0.00044	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.61e-05	0.000432	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.54e-05	0.000424	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.54e-05	0.000423	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.52e-05	0.000421	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.49e-05	0.000417	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.48e-05	0.000416	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.45e-05	0.000413	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.45e-05	0.000413	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.45e-05	0.000412	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.44e-05	0.000411	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.44e-05	0.000411	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.42e-05	0.000409	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.42e-05	0.000409	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.4e-05	0.000407	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.39e-05	0.000405	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.36e-05	0.000401	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.26e-05	0.00039	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.25e-05	0.000389	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.22e-05	0.000385	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.19e-05	0.000381	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.17e-05	0.000379	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.15e-05	0.000376	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.15e-05	0.000376	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.12e-05	0.000373	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.06e-05	0.000365	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.04e-05	0.000363	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.01e-05	0.00036	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.9e-05	0.000347	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.73e-05	0.000326	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.72e-05	0.000325	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.68e-05	0.000321	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.63e-05	0.000315	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.5e-05	0.000299	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.49e-05	0.000297	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.45e-05	0.000293	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.42e-05	0.000289	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	2.4e-05	0.000287	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.39e-05	0.000285	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.37e-05	0.000283	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	2.29e-05	0.000274	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.28e-05	0.000272	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.25e-05	0.000269	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.23e-05	0.000266	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.22e-05	0.000266	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.21e-05	0.000265	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.11e-05	0.000252	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.08e-05	0.000248	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.06e-05	0.000246	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ALB—chronic obstructive pulmonary disease	2.04e-05	0.000244	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.03e-05	0.000243	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.01e-05	0.000241	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.99e-05	0.000238	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—NOS3—chronic obstructive pulmonary disease	1.96e-05	0.000234	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.87e-05	0.000224	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000222	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.85e-05	0.000221	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.83e-05	0.000219	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.83e-05	0.000219	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000217	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.81e-05	0.000217	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.69e-05	0.000202	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.67e-05	0.0002	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.67e-05	0.0002	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.65e-05	0.000198	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.61e-05	0.000192	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.56e-05	0.000187	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.54e-05	0.000184	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.54e-05	0.000184	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.54e-05	0.000184	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.52e-05	0.000182	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.44e-05	0.000172	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.43e-05	0.000171	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.000167	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.38e-05	0.000164	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.37e-05	0.000164	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.36e-05	0.000163	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.28e-05	0.000153	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000153	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.27e-05	0.000152	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.26e-05	0.000151	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.25e-05	0.00015	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000145	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.21e-05	0.000145	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.2e-05	0.000143	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.18e-05	0.000141	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.17e-05	0.00014	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.12e-05	0.000134	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	0.000132	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.09e-05	0.00013	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	0.00012	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	9.25e-06	0.000111	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	8.85e-06	0.000106	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.38e-06	0.0001	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.27e-06	9.89e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	8.26e-06	9.87e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	7.9e-06	9.44e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.7e-06	9.21e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	7.59e-06	9.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	7.53e-06	9e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.3e-06	8.73e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.26e-06	8.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.2e-06	8.61e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.97e-06	5.94e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.75e-06	5.68e-05	CbGpPWpGaD
